Biochem/physiol Actions
Reversible: no
Product does not compete with ATP.
Primary TargetnNOS
Cell permeable: yes
Target IC50: 90 µM against neuronal nitric oxide synthase
General description
Cell permeable. Blocks glibenclamide-sensitive K+ channels (IC50 = 4.4 µM). Inhibits neuronal nitric oxide synthase (IC50 = 90 µM). Also inhibits hepatic drug metabolism by inhibiting the cytochrome P-450 system. Stimulates endothelial cell prostocyclin production while inhibiting platelet thromboxane synthesis. Potentiates the effect of many drugs in vivo.
Cell permeable. Blocks glibenclamide-sensitive K+ channels. Inhibits neuronal nitric oxide synthase (IC50 = 90 µM). Also inhibits hepatic drug metabolism by inhibiting the cytochrome P450 system. Stimulates endothelial cell prostacyclin production while inhibiting platelet thromboxane synthesis. Potentiates the action of many drugs in vivo.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Hecker, M., et al. 1994. J. Neurochem. 62, 1524.Sakuta, H. and Yoneda, I. 1994. Eur. J. Pharmacol.252, 117.Khan, S., et al. 1993. Biochem. Pharmacol.45, 439.Boeynaems, J.M., et al. 1986. Prostaglandins32, 145.Lee, C.H., et al. 1976. J. Pharmacol. Exp. Ther.198, 347.Grasdalen, J., et al. 1975. FEBS Lett.60, 240.
Packaging
1 g in Plastic ampoule
Reconstitution
Following reconstitution, store in the refrigerator(4°C). Stock solutions are stable for up to 6 months at 4°C.
Warning
Toxicity: Harmful (C)
This product has met the following criteria to qualify for the following awards: